139 related articles for article (PubMed ID: 31452800)
1. Original tumour suppressor gene polycystic kidney and hepatic disease 1-like 1 is associated with thyroid cancer cell progression.
Zheng C; Quan R; Xia EJ; Bhandari A; Zhang X
Oncol Lett; 2019 Sep; 18(3):3227-3235. PubMed ID: 31452800
[TBL] [Abstract][Full Text] [Related]
2. Scavenger receptor class A, member 5 is associated with thyroid cancer cell lines progression via epithelial-mesenchymal transition.
Zheng C; Xia EJ; Quan RD; Bhandari A; Wang OC; Hao RT
Cell Biochem Funct; 2020 Mar; 38(2):158-166. PubMed ID: 31989658
[TBL] [Abstract][Full Text] [Related]
3. Low metallothionein 1M (MT1M) is associated with thyroid cancer cell lines progression.
Chen Y; Quan R; Bhandari A; Chen Z; Guan Y; Xiang J; You J; Teng L
Am J Transl Res; 2019; 11(3):1760-1770. PubMed ID: 30972199
[TBL] [Abstract][Full Text] [Related]
4. GABRB2 plays an important role in the lymph node metastasis of papillary thyroid cancer.
Jin Y; Jin W; Zheng Z; Chen E; Wang Q; Wang Y; Wang O; Zhang X
Biochem Biophys Res Commun; 2017 Oct; 492(3):323-330. PubMed ID: 28859983
[TBL] [Abstract][Full Text] [Related]
5. NECTIN4 promotes papillary thyroid cancer cell proliferation, migration, and invasion and triggers EMT by activating AKT.
Hao RT; Zheng C; Wu CY; Xia EJ; Zhou XF; Quan RD; Zhang XH
Cancer Manag Res; 2019; 11():2565-2578. PubMed ID: 31114323
[TBL] [Abstract][Full Text] [Related]
6. New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.
Saiselet M; Gacquer D; Spinette A; Craciun L; Decaussin-Petrucci M; Andry G; Detours V; Maenhaut C
BMC Genomics; 2015 Oct; 16():828. PubMed ID: 26487287
[TBL] [Abstract][Full Text] [Related]
7. Ribonucleotide reductase large subunit M1 plays a different role in the invasion and metastasis of papillary thyroid carcinoma and undifferentiated thyroid carcinoma.
Fang Z; Song R; Gong C; Zhang X; Ren G; Li J; Chen Y; Qiu L; Mei L; Zhang R; Xiang X; Chen X; Shao J
Tumour Biol; 2016 Mar; 37(3):3515-26. PubMed ID: 26453115
[TBL] [Abstract][Full Text] [Related]
8. CITED1 gene promotes proliferation, migration and invasion in papillary thyroid cancer.
Xia E; Wang Y; Bhandari A; Niu J; Yang F; Yao Z; Wang O
Oncol Lett; 2018 Jul; 16(1):105-112. PubMed ID: 29928391
[TBL] [Abstract][Full Text] [Related]
9. LRP4 promotes proliferation, migration, and invasion in papillary thyroid cancer.
Zhou X; Xia E; Bhandari A; Zheng C; Xiang J; Guan Y; Zhang X
Biochem Biophys Res Commun; 2018 Sep; 503(1):257-263. PubMed ID: 29885843
[TBL] [Abstract][Full Text] [Related]
10. A novel tumor suppressor gene
Zheng ZC; Wang QX; Zhang W; Zhang XH; Huang DP
Onco Targets Ther; 2018; 11():307-311. PubMed ID: 29391807
[TBL] [Abstract][Full Text] [Related]
11. lncRNA LINC00673 induces proliferation, metastasis and epithelial-mesenchymal transition in thyroid carcinoma via Kruppel-like factor 2.
Xia E; Bhandari A; Shen Y; Zhou X; Wang O
Int J Oncol; 2018 Nov; 53(5):1927-1938. PubMed ID: 30106140
[TBL] [Abstract][Full Text] [Related]
12. SYT12 is a novel oncogene that promotes thyroid carcinoma progression and metastasis.
Jin L; Zheng D; Chen D; Xia E; Guan Y; Wen J; Bhandari A; Wang O
J Cancer; 2021; 12(22):6851-6860. PubMed ID: 34659573
[No Abstract] [Full Text] [Related]
13. Upregulated LAMB3 increases proliferation and metastasis in thyroid cancer.
Wang Y; Jin Y; Bhandari A; Yao Z; Yang F; Pan Y; Zheng Z; Lv S; Wang O
Onco Targets Ther; 2018; 11():37-46. PubMed ID: 29317832
[TBL] [Abstract][Full Text] [Related]
14. Fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis.
Xia S; Wang C; Postma EL; Yang Y; Ni X; Zhan W
Onco Targets Ther; 2017; 10():1743-1755. PubMed ID: 28367057
[TBL] [Abstract][Full Text] [Related]
15. Next-generation sequence detects
Wang QX; Chen ED; Cai YF; Zhou YL; Zheng ZC; Wang YH; Jin YX; Jin WX; Zhang XH; Wang OC
Onco Targets Ther; 2016; 9():7161-7167. PubMed ID: 27920554
[TBL] [Abstract][Full Text] [Related]
16. Underexpression of INPPL1 is associated with aggressive clinicopathologic characteristics in papillary thyroid carcinoma.
Zhou YL; Zheng C; Chen YT; Chen XM
Onco Targets Ther; 2018; 11():7725-7731. PubMed ID: 30464521
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of CDH16 in Papillary Thyroid Cancer and Its Potential Molecular Mechanism Analysed by qRT-PCR, TCGA and in silico Analysis.
Li P; Wu Q; Sun Y; Pan X; Han Y; Ye B; Zhang Y; Dong J; Zheng Z
Cancer Manag Res; 2019; 11():10719-10729. PubMed ID: 31920382
[TBL] [Abstract][Full Text] [Related]
18. Concomitant high expression of ERα36, GRP78 and GRP94 is associated with aggressive papillary thyroid cancer behavior.
Dai YJ; Qiu YB; Jiang R; Xu M; Liao LY; Chen GG; Liu ZM
Cell Oncol (Dordr); 2018 Jun; 41(3):269-282. PubMed ID: 29368272
[TBL] [Abstract][Full Text] [Related]
19. Integrated microRNA, gene expression and transcription factors signature in papillary thyroid cancer with lymph node metastasis.
Ab Mutalib NS; Othman SN; Mohamad Yusof A; Abdullah Suhaimi SN; Muhammad R; Jamal R
PeerJ; 2016; 4():e2119. PubMed ID: 27350898
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of long non-coding RNA NR_036575.1 contributes to the proliferation and migration of papillary thyroid cancer.
Sun W; Lan X; Wang Z; Dong W; He L; Zhang T; Zhang H
Med Oncol; 2016 Sep; 33(9):102. PubMed ID: 27510368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
